| |||||||
Former Names A.BY-H2b H2-T18b/SnJ-Dstncorn1/J (Changed: 15-DEC-04 ) A.BY-H2b H2-T18b/SnJ-corn1 (Changed: 15-DEC-04 ) A.BY/SnJ-corn1 (Changed: 15-DEC-04 ) Type Congenic; Major Histocompatibility Congenic; Mutant Strain; Additional information on Genetically Engineered Mutant Mice. Mating System Homozygote x Homozygote (Female x Male) Species laboratory mouse Appearance
albino, vascularized cornea, cataract
Related Genotype: a/a Tyrp1b/Tyrp1b Tyrc/Tyrc Dstncorn1/Dstncorn1Description
Mice homozygous for the recessive Dstncorn1 mutation have abnormally proliferative basal corneal epithelial cells. Focal areas of corneal epithelial hyperplasia are found by one week of age, and neovascularization is found by 14 days of age when the eyes open. This neovascularization, which progresses during the first two months of age, is not found in mice homozygous for the Dstncorn-2J allele (which is a point mutation leading to a change in a single amino acid residue). In both mutants the corneal epithelial cells show increased levels and altered organizational pattern of filamentous actin. The areas of thickened cortical epithelia yield a roughened, opaque corneal surface.At 4 weeks of age in Dstncorn1 homozygotes, expression of keratin 14 and involucrin extend into the suprabasal layer in the areas of hyperplastic corneal epithelia. There is also an increase in the levels of expression of cofilin 1, lumican and keratocan with lumican showing abnormal expression in epithelial cells. (Smith et al., 1996; Wang et al., 2001; Ikeda et al., 2003.) Homozygotes develop hemangiogenesis at 4 weeks of age; onset of lymphangiogenesis is delayed, less intense and regresses earlier compared with hemangiogenesis. (Cursiefen et al., 2005).
| Control | ||
|---|---|---|
| 000646 A/J | ||
| Considerations for Choosing Controls | ||
Congenic Nomenclature
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
Dstncorn1/Dstncorn1
A.By-H2b/SnJ
- vision/eye phenotype
- abnormal corneal epithelium morphology (MGI Ref ID J:114973)
- focal areas ~1 mm in diameter are elevated above corneal surface
- epithelium has "dry", white appearance
- at 12 days of age, mice show mild edema of basal epithelial layers and corneal surface shows irregularities with focal areas ~1 mm in diameter elevated above corneal surface; corneal surface is increasingly roughened and irregular, until 70 days of age when irregularity stabilizes
- at 21 and 30 days of age, thickening of epithelium increases
- surface epithelial cell nuclei are pyknotic and cytoplasm has granular appearance
- eosinophilia is seen in superficial epithelial cells at 12 days of age, but is decreased by 60 days of age
- at 4 weeks of age the hyperplastic corneal epithelium has altered expression of keratin 14, involucrin, and lumican
- cataracts (MGI Ref ID J:31798)
- bilateral cataracts develop by 45-50 days of age; progressive lenticular opacification is observed to 8 months of age
- cataracts are manifested by liquefaction of lens fibers and posterior migration of lens epithelial nuclei
- corneal vascularization (MGI Ref ID J:98465)
- mice exhibit spontaneous corneal vascularization
- corneal injection of sflt-1 (secreted isoform of the cell surface receptor membrane-bound Flt1) protein reduces the area of vascularization compared to untreated mutants
- neovascularization is present in limbus at E18; vascularization grows and reaches center of cornea at 45 days
- cellular phenotype
- increased cell proliferation (MGI Ref ID J:31798)
- in homozygotes, there are 10-fold more proliferating corneal epithelial cells than in wild-type or heterozygous mice
- cardiovascular system phenotype
- increased angiogenesis (MGI Ref ID J:98465)
- in the cornea
- pathological neovascularization (MGI Ref ID J:98465)
- hemangiogenesis in the normally avascular cornea is first seen as single sprouts around 2 weeks of age, by 3 weeks of age slit-lamp examination shows outgrowth of limbal blood vessels, and blood vessels cover the corneal surface by approximately 6 weeks of age.
- corneal hemangiogenesis precedes lymphangiogenesis by approximately one week, and there is no corneal blood vessel regression in the first year.
- Corneal hemangiogenesis and lymphangiogenesis can be inhibited by treatment with an antibody blocking vascular enothelial growht factor receptor 3
- immune system phenotype
- *normal* immune system phenotype (MGI Ref ID J:98465)
- the aqueous humor has a normal protein and leukocyte count indicating that the corneal neovascularization and lymphangiogenesis are not mediated primarily by inflammation
- lymphangiogenesis (MGI Ref ID J:98465)
- Corneal lymphangiogenesis begins with small sprouts around 3 weeks of age, a week after corneal hemangiogenesis begins, and lymphatic vessels are clearly visible by 4 to 6 weeks of age. Vessel fragmentation is seen as early as 2 months of age. Thus, corneal lymphangiogenesis is less severe than hemangiogenesis and comparatively delayed.
- This corneal lymphangiogenesis occurs in a low inflammatory context in which there are only slightly more CD45 positive cells at 4 weeks of age than in controls.
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:Dstncorn1 related
Cancer Research
Other (tumor metastasis)
Cardiovascular Research
Vascular Defects
Cell Biology Research
Cell Cycle Regulation
Genes Regulating Growth and Proliferation
Post-translational Processing
Signal Transduction
Developmental Biology Research
Eye Defects
Sensorineural Research
Cataracts (cortical)
Eye Defects
| Allele Symbol | Dstncorn1 | ||
|---|---|---|---|
| Allele Name | corneal disease 1 | ||
| Allele Type | Spontaneous | ||
| Common Name(s) | corn1; | ||
| Strain of Origin | A.By-H2/SnJ | ||
| Gene Symbol and Name | Dstn, destrin | ||
| Chromosome | 2 | ||
| Gene Common Name(s) | 2610043P17Rik; ACTDP; ADF; AU042046; RIKEN cDNA 2610043P17 gene; bA462D18.2; corn1; corneal disease 1; expressed sequence AU042046; sid23p; | ||
| Molecular Note | The mutation in the corn1 mouse was identified as a 35 kb deletion encompassing the entire coding region of the gene. [MGI Ref ID J:83125] | ||
| Gene Symbol and Name | H2-T18, histocompatibility 2, T region locus 18 | ||
| Chromosome | 17 | ||
| Gene Common Name(s) | H-2T18; TL Ag; Tla; thymus leukemia antigen; | ||
| Gene Symbol and Name | H2, histocompatibility-2, MHC | ||
| Chromosome | 17 | ||
| Gene Common Name(s) | H-2; MHC-II; | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Optimizing PCR Protocols
Ikeda S; Cunningham LA; Boggess D; Hobson CD; Sundberg JP; Naggert JK; Smith RS; Nishina PM. 2003. Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Hum Mol Genet 12(9):1029-37. [PubMed: 12700171] [MGI Ref ID J:83125]
Wang I; Kao CW; Liu C; Saika S; Nishina PM; Sundberg JP; Smith RS; Kao WW. 2001. Characterization of Corn1 mice: Alteration of epithelial and stromal cell gene expression. Mol Vis 7:20-6. [PubMed: 11182022] [MGI Ref ID J:83043]
Dstncorn1 relatedAmbati BK; Nozaki M; Singh N; Takeda A; Jani PD; Suthar T; Albuquerque RJ; Richter E; Sakurai E; Newcomb MT; Kleinman ME; Caldwell RB; Lin Q; Ogura Y; Orecchia A; Samuelson DA; Agnew DW; St Leger J; Green WR; Mahasreshti PJ; Curiel DT; Kwan D; Marsh H; Ikeda S; Leiper LJ; Collinson JM; Bogdanovich S; Khurana TS; Shibuya M; Baldwin ME; Ferrara N; Gerber HP; De Falco S; Witta J; Baffi JZ; Raisler BJ; Ambati J. 2006. Corneal avascularity is due to soluble VEGF receptor-1. Nature 443(7114):993-7. [PubMed: 17051153] [MGI Ref ID J:114973]
Cursiefen C; Ikeda S; Nishina PM; Smith RS; Ikeda A; Jackson D; Mo JS; Chen L; Dana MR; Pytowski B; Kruse FE; Streilein JW. 2005. Spontaneous Corneal Hem- and Lymphangiogenesis in Mice with Destrin-Mutation Depend on VEGFR3 Signaling. Am J Pathol 166(5):1367-77. [PubMed: 15855638] [MGI Ref ID J:98465]
Ikeda S; Cunningham LA; Boggess D; Hobson CD; Sundberg JP; Naggert JK; Smith RS; Nishina PM. 2003. Aberrant actin cytoskeleton leads to accelerated proliferation of corneal epithelial cells in mice deficient for destrin (actin depolymerizing factor). Hum Mol Genet 12(9):1029-37. [PubMed: 12700171] [MGI Ref ID J:83125]
Kousaka K; Kiyonari H; Oshima N; Nagafuchi A; Shima Y; Chisaka O; Uemura T. 2008. Slingshot-3 dephosphorylates ADF/cofilin but is dispensable for mouse development. Genesis 46(5):246-55. [PubMed: 18442045] [MGI Ref ID J:136245]
Smith RS; Hawes NL; Kuhlmann SD; Heckenlively JR; Chang B; Roderick TH; Sundberg JP. 1996. Corn1: a mouse model for corneal surface disease and neovascularization. Invest Ophthalmol Vis Sci 37(2):397-404. [PubMed: 8603845] [MGI Ref ID J:31798]
Verdoni AM; Smith RS; Ikeda A; Ikeda S. 2008. Defects in actin dynamics lead to an autoinflammatory condition through the upregulation of CXCL5. PLoS ONE 3(7):e2701. [PubMed: 18628996] [MGI Ref ID J:139239]
Wang I; Kao CW; Liu C; Saika S; Nishina PM; Sundberg JP; Smith RS; Kao WW. 2001. Characterization of Corn1 mice: Alteration of epithelial and stromal cell gene expression. Mol Vis 7:20-6. [PubMed: 11182022] [MGI Ref ID J:83043]
Animal Health Reports
Room Number A1
Colony Maintenance
Mating System Homozygote x Homozygote (Female x Male)
| Pricing for USA, Canada and Mexico shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $91.40 Female or Male Homozygous for Dstncorn1 *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $182.80 Homozygous for Dstncorn1 x Homozygous for Dstncorn1
| Supply Notes |
|
|---|
| Pricing for International shipping destinations |
|
Weeks of Age Price* Gender Genotypes Provided Individual Mouse Price $118.90 Female or Male Homozygous for Dstncorn1 *Price(s) in US dollars ($)
Pairs /Price* Pair Genotype $237.70 Homozygous for Dstncorn1 x Homozygous for Dstncorn1
| Supply Notes |
|
|---|
| Standard Supply | Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of ~nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and larger quantities of mice are easily arranged. Estimated ship dates for all orders provided within 48 hours of order placement. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 000646 A/J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. THE LABORATORY EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of MICE, products or services, The Jackson Laboratory will, at its option, provide credit or replacement for the MICE or product received or the services provided.
In no event shall The Jackson Laboratory, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, products or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of The Jackson Laboratory, its agents or employees. In purchasing or receiving MICE, products or services from The Jackson Laboratory, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges The Jackson Laboratory from all such causes of action or damages, and further agrees to defend and indemnify The Jackson Laboratory from any costs or damages arising out of any third party claims.
MICE and biological materials are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to The Jackson Laboratory’s MICE, products and services. In addition, special terms and conditions of sale of certain MICE, products and services may be set forth separately in The Jackson Laboratory web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, products and services by The Jackson Laboratory, and by its licensees and distributors.
Acceptance of delivery of MICE, products or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on The Jackson Laboratory, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, products services by The Jackson Laboratory.